CXCL8
type: EnsemblDatabaseReference

IER2
type: EnsemblDatabaseReference

(Assay) Uninfected control_0c
type: Assay
identifier: Uninfected control_0c
has participant: A-AFFY-41

(Assay) Uninfected control_4c
type: Assay
identifier: Uninfected control_4c
has participant: A-AFFY-41

(Sample) cell line/HEK 293
type: EFO_0000001
property type: cell line
property value: HEK 293

TNFRSF9
type: EnsemblDatabaseReference

JUND
type: EnsemblDatabaseReference

GADD45A
type: EnsemblDatabaseReference

HNRNPA0 DOWN in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: DecreasedDifferentialExpressionRatio
fold change: -1.02145738837837
p value: 1.40301806089238E-5
refers to: HNRNPA0
refers to: 201055_s_at
t statistic: -11.3336813513592

NFKBIA
type: EnsemblDatabaseReference

(Assay) LacZ control_0b
type: Assay
identifier: LacZ control_0b
has participant: A-AFFY-41

201631_s_at
type: EFO_0005072
part of: A-AFFY-41

(Assay) RelA_siRNA_4a
type: Assay
has participant: A-AFFY-41

201502_s_at
type: EFO_0005072
part of: A-AFFY-41

(Assay) LacZ control_0c
type: Assay
identifier: LacZ control_0c
has participant: A-AFFY-41

205205_at
type: EFO_0005072
part of: A-AFFY-41

PTGS2
type: EnsemblDatabaseReference

KIF20A DOWN in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: DecreasedDifferentialExpressionRatio
fold change: -1.32601295107233
p value: 1.90853378477485E-8
refers to: KIF20A
refers to: 218755_at
t statistic: -23.2632509180692

(Factor value) RNA_INTERFERENCE/p53 knockdown
type: EFO_0000001
property type: RNA_INTERFERENCE
property value: p53 knockdown

203752_s_at
type: EFO_0005072
part of: A-AFFY-41

(Assay) RelA_siRNA_4c
type: Assay
has participant: A-AFFY-41

(Assay) ATM_siRNA_0c
type: Assay
has participant: A-AFFY-41

(Assay) LacZ control_4b
type: Assay
identifier: LacZ control_4b
has participant: A-AFFY-41

CXCL2 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.77677646111789
p value: 0.0498329160985331
refers to: CXCL2
refers to: 209774_x_at
t statistic: 4.57595510803409

(Assay) LacZ control_4a
type: Assay
identifier: LacZ control_4a
has participant: A-AFFY-41

207536_s_at
type: EFO_0005072
part of: A-AFFY-41

IER3 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.14130924511593
p value: 0.00118955689687452
refers to: 201631_s_at
refers to: IER3
t statistic: 10.0115235169591

GADD45B
type: EnsemblDatabaseReference

TNFAIP3
type: EnsemblDatabaseReference

(Assay) ATM_siRNA_4c
type: Assay
has participant: A-AFFY-41

KIF20A
type: EnsemblDatabaseReference

CCL20
type: EnsemblDatabaseReference

ATF3
type: EnsemblDatabaseReference

202644_s_at
type: EFO_0005072
part of: A-AFFY-41

(Factor value) RNA_INTERFERENCE/ATM knockdown
type: EFO_0000001
property type: RNA_INTERFERENCE
property value: ATM knockdown

IER2
type: EnsemblDatabaseReference

(Assay) Uninfected control_4b
type: Assay
identifier: Uninfected control_4b
has participant: A-AFFY-41

(Assay) ATM_siRNA_0a
type: Assay
has participant: A-AFFY-41

(Assay) RelA_siRNA_0a
type: Assay
has participant: A-AFFY-41

A-AFFY-41
type: EFO_0000269

TNFRSF9
type: EnsemblDatabaseReference

GADD45A
type: EnsemblDatabaseReference

DUSP1
type: EnsemblDatabaseReference

204470_at
type: EFO_0005072
part of: A-AFFY-41

PLK1 DOWN in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: DecreasedDifferentialExpressionRatio
fold change: -1.05987688730732
p value: 9.30200923671693E-4
refers to: PLK1
refers to: 202240_at
t statistic: -11.2440868700437

GADD45B UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.90414040149713
p value: 1.35110430797232E-4
refers to: GADD45B
refers to: 207574_s_at
t statistic: 15.2984904111355

204440_at
type: EFO_0005072
part of: A-AFFY-41

IER3 UP in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.28433341217289
p value: 4.70895846328466E-8
refers to: IER3
refers to: 201631_s_at
t statistic: 19.516263525904

202240_at
type: EFO_0005072
part of: A-AFFY-41

CXCL1
type: EnsemblDatabaseReference

DUSP1 UP in 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.81579698309126
p value: 0.0211249960899843
refers to: DUSP1
refers to: 201041_s_at
t statistic: 9.55585078230309

PTX3
type: EnsemblDatabaseReference

TFPI2
type: EnsemblDatabaseReference

(Assay) ATM_siRNA_0b
type: Assay
has participant: A-AFFY-41

CD83 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.82997061343457
p value: 9.30200923671693E-4
refers to: 204440_at
refers to: CD83
t statistic: 11.0264068966567

TNFAIP3 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 3.07118170299396
p value: 6.10383448085175E-6
refers to: TNFAIP3
refers to: 202644_s_at
t statistic: 28.22754458178

(Assay) p53_siRNA_4c
type: Assay
has participant: A-AFFY-41

NFKBIA UP in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.36676840797439
p value: 2.88582902761962E-8
refers to: 201502_s_at
refers to: NFKBIA
t statistic: 21.2979316803895

205476_at
type: EFO_0005072
part of: A-AFFY-41

ATF3 UP in 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 2.87393531268456
p value: 0.00478369032783418
refers to: ATF3
refers to: 202672_s_at
t statistic: 15.0180975774685

GADD45B
type: EnsemblDatabaseReference

CXCL2
type: EnsemblDatabaseReference

CCL20
type: EnsemblDatabaseReference

SDC4
type: EnsemblDatabaseReference

ATF3
type: EnsemblDatabaseReference

202071_at
type: EFO_0005072
part of: A-AFFY-41

ATF3 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.97223600636296
p value: 0.0280314432658381
refers to: ATF3
refers to: 202672_s_at
t statistic: 5.09893343882272

JUND UP in 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.43140075999084
p value: 0.0117610937205339
refers to: JUND
refers to: 203752_s_at
t statistic: 10.9283131686601

(Assay) p53_siRNA_4a
type: Assay
has participant: A-AFFY-41

ATF3 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.78889534308238
p value: 1.35110430797232E-4
refers to: ATF3
refers to: 202672_s_at
t statistic: 15.654181226914

PTGS2
type: EnsemblDatabaseReference

IER3
type: EnsemblDatabaseReference

211506_s_at
type: EFO_0005072
part of: A-AFFY-41

(Assay) ATM_siRNA_4a
type: Assay
has participant: A-AFFY-41

218755_at
type: EFO_0005072
part of: A-AFFY-41

(Assay) Uninfected_control_0a
type: Assay
has participant: A-AFFY-41

RELB
type: EnsemblDatabaseReference

209277_at
type: EFO_0005072
part of: A-AFFY-41

(Factor value) RNA_INTERFERENCE/LacZ control
type: EFO_0000001
property type: RNA_INTERFERENCE
property value: LacZ control

Homo sapiens
type: OBI_0100026

(Assay) ATM_siRNA_4b
type: Assay
has participant: A-AFFY-41

EGR1
type: EnsemblDatabaseReference

PTX3 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.92597148451268
p value: 0.0181846736404813
refers to: 206157_at
refers to: PTX3
t statistic: 5.84198105039249

CD83
type: EnsemblDatabaseReference

(Assay) RelA_siRNA_0c
type: Assay
has participant: A-AFFY-41

DUSP1 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.03220103131286
p value: 0.00173915035431056
refers to: 201041_s_at
refers to: DUSP1
t statistic: 9.3384699488109

NFKBIA UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.48090126840244
p value: 0.00197805137915225
refers to: NFKBIA
refers to: 201502_s_at
t statistic: 9.48484640598451

201694_s_at
type: EFO_0005072
part of: A-AFFY-41

GADD45B UP in 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.22886414784226
p value: 0.0117610937205339
refers to: 207574_s_at
refers to: GADD45B
t statistic: 10.8149436949686

204748_at
type: EFO_0005072
part of: A-AFFY-41

PLK1
type: EnsemblDatabaseReference

203725_at
type: EFO_0005072
part of: A-AFFY-41

(Assay) RelA_siRNA_4b
type: Assay
has participant: A-AFFY-41

TNFRSF9 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.94671201408755
p value: 0.013630022889371
refers to: 207536_s_at
refers to: TNFRSF9
t statistic: 6.3060927942971

(Assay) RelA_siRNA_0b
type: Assay
has participant: A-AFFY-41

TFPI2 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.58863123619666
p value: 0.0458755867417715
refers to: 209277_at
refers to: TFPI2
t statistic: 4.70707165534353

TFPI2
type: EnsemblDatabaseReference

CXCL1 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.50293596089584
p value: 0.00369979995193089
refers to: CXCL1
refers to: 204470_at
t statistic: 8.13585622694004

PTGS2 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.38898017788769
p value: 0.013630022889371
refers to: PTGS2
refers to: 204748_at
t statistic: 6.17210462140278

CXCL2 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.08550055794217
p value: 0.0181096701877545
refers to: 209774_x_at
refers to: CXCL2
t statistic: 5.63802538677045

CD83 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.62848573171707
p value: 3.56065245021877E-4
refers to: CD83
refers to: 204440_at
t statistic: 14.0735772880417

202081_at
type: EFO_0005072
part of: A-AFFY-41

CXCL1 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.97057222288843
p value: 3.56065245021877E-4
refers to: CXCL1
refers to: 204470_at
t statistic: 14.728178431052

GADD45A UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.28811480028771
p value: 9.30200923671693E-4
refers to: 203725_at
refers to: GADD45A
t statistic: 10.8460116170475

(Assay) p53_siRNA_0c
type: Assay
has participant: A-AFFY-41

207574_s_at
type: EFO_0005072
part of: A-AFFY-41

SDC4 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.43717952589009
p value: 7.50599134308489E-4
refers to: SDC4
refers to: 202071_at
t statistic: 11.9127248306065

CXCL2
type: EnsemblDatabaseReference

SDC4
type: EnsemblDatabaseReference

(Assay) p53_siRNA_0a
type: Assay
has participant: A-AFFY-41

PTX3
type: EnsemblDatabaseReference

NFKBIA UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.29187124955873
p value: 2.14760592637909E-5
refers to: 201502_s_at
refers to: NFKBIA
t statistic: 22.0617743131569

EGR1 UP in 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 2.74456295316063
p value: 3.14246473549217E-4
refers to: 201694_s_at
refers to: EGR1
t statistic: 26.0455815680835

(Assay) LacZ control_0a
type: Assay
identifier: LacZ control_0a
has participant: A-AFFY-41

(Factor value) COMPOUND/neocarzinostatin
type: CHEBI_29655
property type: COMPOUND
property value: neocarzinostatin

RELB
type: EnsemblDatabaseReference

Analysis of 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: MicroarrayDifferentialExpressionAnalysis

CCL20 UP in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.50616214551435
p value: 6.03559780548137E-8
refers to: CCL20
refers to: 205476_at
t statistic: 18.8189775654797

CXCL8 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.29535104029906
p value: 3.56065245021877E-4
refers to: CXCL8
refers to: 211506_s_at
t statistic: 17.558765875734

CCL20 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 3.31483294058086
p value: 1.35110430797232E-4
refers to: CCL20
refers to: 205476_at
t statistic: 15.8899454488266

IER3 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.38965240207181
p value: 0.00357183135505397
refers to: 201631_s_at
refers to: IER3
t statistic: 8.16381384527941

CD83
type: EnsemblDatabaseReference

201055_s_at
type: EFO_0005072
part of: A-AFFY-41

IER2 UP in 'neocarzinostatin' vs 'none' in 'RelA knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.37182271950892
p value: 0.0412730770587714
refers to: IER2
refers to: 202081_at
t statistic: 8.33735793941442

CENPA DOWN in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: DecreasedDifferentialExpressionRatio
fold change: -1.13513251825449
p value: 1.35625069645063E-7
refers to: CENPA
refers to: 204962_s_at
t statistic: -17.2189416712162

(Sample) organism/Homo sapiens
type: Homo sapiens
property type: organism
property value: Homo sapiens

TNFAIP3 UP in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.62920587680261
p value: 1.24669636226602E-7
refers to: TNFAIP3
refers to: 202644_s_at
t statistic: 17.5409850116893

(Assay) p53_siRNA_4b
type: Assay
has participant: A-AFFY-41

HNRNPA0
type: EnsemblDatabaseReference

CENPA
type: EnsemblDatabaseReference

(Sample) cell type/embryonic kidney cell
type: EFO_0001182
property type: cell type
property value: embryonic kidney cell

IER3
type: EnsemblDatabaseReference

209774_x_at
type: EFO_0005072
part of: A-AFFY-41

CXCL8
type: EnsemblDatabaseReference

Analysis of 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: MicroarrayDifferentialExpressionAnalysis

RELB UP in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.55830448535592
p value: 2.88582902761962E-8
refers to: 205205_at
refers to: RELB
t statistic: 20.7193576454109

EGR1
type: EnsemblDatabaseReference

(Assay) p53_siRNA_0b
type: Assay
has participant: A-AFFY-41

(Assay) Uninfected control_0b
type: Assay
identifier: Uninfected control_0b
has participant: A-AFFY-41

JUND
type: EnsemblDatabaseReference

NFKBIA
type: EnsemblDatabaseReference

PLK1
type: EnsemblDatabaseReference

(Assay) Uninfected control_4a
type: Assay
identifier: Uninfected control_4a
has participant: A-AFFY-41

(Factor value) RNA_INTERFERENCE/RelA knockdown
type: EFO_0000001
property type: RNA_INTERFERENCE
property value: RelA knockdown

CXCL8 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 3.57807484301925
p value: 6.10383448085175E-6
refers to: CXCL8
refers to: 211506_s_at
t statistic: 28.0021158237133

(Assay) LacZ control_4c
type: Assay
identifier: LacZ control_4c
has participant: A-AFFY-41

Analysis of 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: MicroarrayDifferentialExpressionAnalysis

(Factor value) RNA_INTERFERENCE/RNA interference control
type: EFO_0000001
property type: RNA_INTERFERENCE
property value: RNA interference control

204962_s_at
type: EFO_0005072
part of: A-AFFY-41

TNFAIP3 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.45353945922817
p value: 8.4350747050489E-4
refers to: 202644_s_at
refers to: TNFAIP3
t statistic: 11.311174727749

TNFRSF9 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.69909914299129
p value: 0.00318189436564551
refers to: TNFRSF9
refers to: 207536_s_at
t statistic: 8.51269601694213

TNFRSF9 UP in 'neocarzinostatin' vs 'none' in 'p53 knockdown'
type: IncreasedDifferentialExpressionRatio
fold change: 1.04032667203686
p value: 1.59616046739194E-5
refers to: 207536_s_at
refers to: TNFRSF9
t statistic: 11.0248077858813

E-GEOD-1676
type: microarray 1colour mrna differential
RO_0002162: Homo sapiens
description: Response to treatment with the radiomimetic drug NCS in cells knocked-down for ATM, p53, and the Rel_A subunit of NFkB; and in control un-infected cells and cells infected with siRNA against LacZ
uses data from: http://identifiers.org/pubmed/15892871

PLK1 DOWN in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: DecreasedDifferentialExpressionRatio
fold change: -1.06720853850779
p value: 0.00772589275316994
refers to: PLK1
refers to: 202240_at
t statistic: -6.83729561006074

202672_s_at
type: EFO_0005072
part of: A-AFFY-41

DUSP1
type: EnsemblDatabaseReference

206157_at
type: EFO_0005072
part of: A-AFFY-41

201041_s_at
type: EFO_0005072
part of: A-AFFY-41

CXCL1
type: EnsemblDatabaseReference

Analysis of 'neocarzinostatin' vs 'none' in 'LacZ control'
type: MicroarrayDifferentialExpressionAnalysis

TNFAIP3
type: EnsemblDatabaseReference

KIF20A
type: EnsemblDatabaseReference

HNRNPA0
type: EnsemblDatabaseReference

(Factor value) COMPOUND/none
type: EFO_0001461
property type: COMPOUND
property value: none

CENPA
type: EnsemblDatabaseReference

EGR1 UP in 'neocarzinostatin' vs 'none' in 'RNA interference control'
type: IncreasedDifferentialExpressionRatio
fold change: 1.6476167548778
p value: 0.00185836854291347
refers to: 201694_s_at
refers to: EGR1
t statistic: 9.14098640923699

CCL20 UP in 'neocarzinostatin' vs 'none' in 'LacZ control'
type: IncreasedDifferentialExpressionRatio
fold change: 2.15961994168019
p value: 3.56065245021877E-4
refers to: CCL20
refers to: 205476_at
t statistic: 14.4555619044199